These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2810332)

  • 1. 3-Sulfonyl-1-carba-1-dethiacephems.
    Crowell TA; Halliday BD; McDonald JH; Indelicato JM; Pasini CE; Wu EC
    J Med Chem; 1989 Nov; 32(11):2436-42. PubMed ID: 2810332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Quaternary ammonium 1-carba-1-dethiacephems.
    Cook GK; McDonald JH; Alborn W; Boyd DB; Eudaly JA; Indelicato JM; Johnson R; Kasher JS; Pasini CE; Preston DA
    J Med Chem; 1989 Nov; 32(11):2442-50. PubMed ID: 2810333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antibacterial activities of 3-thiazol-4-yl-1-carba-1-dethiacephalosporins.
    Hornback WJ; Munroe JE; Counter FT
    J Antibiot (Tokyo); 1994 Sep; 47(9):1052-64. PubMed ID: 7928693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specificities of antibacterial activity of zwitterionic 7-methoxyimino cephems (cephalosporins of fourth generation].
    Pechère JC
    Pathol Biol (Paris); 1996 Feb; 44(2):99-105. PubMed ID: 8761594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T; Otsuki M; Hatano K; Nishihara Y
    Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical laboratory approach for estimating effective administrative dose of cefuzonam. Evaluation of disc susceptibility test and its interpretation system].
    Uete T; Matsuo K
    Jpn J Antibiot; 1988 Oct; 41(10):1407-17. PubMed ID: 3204654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of new cephalosporins with lactonyloxyimino moiety.
    Suh KH; Park JW
    Arch Pharm Res; 1994 Apr; 17(2):87-92. PubMed ID: 10319137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and antimicrobial activity of 7-acylamido-3-1, 2, 3-triazol-1-ylmethyl) cephalosporins].
    Zhang CY; Hu SC; Zhou HS; Duan TH
    Yao Xue Xue Bao; 1991; 26(3):175-82. PubMed ID: 1957657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
    Cullmann W; Dick W; Stieglitz M; Opferkuch W
    Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Takanashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Kosakai N; Yamaguchi K; Matsumoto T; Kashitani F; Tanaka M
    Jpn J Antibiot; 1997 Mar; 50(3):219-50. PubMed ID: 9575353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro antibacterial activity of L-105, a new cephalosporin.
    Hikida M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and beta-lactamase stability on the pKa of the C-7 heterocycle.
    Jung F; Delvare C; Boucherot D; Hamon A; Ackerley N; Betts MJ
    J Med Chem; 1991 Mar; 34(3):1110-6. PubMed ID: 2002452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
    Suzuki Y; Nishinari C; Endo H; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semisynthetic cephalosporins. Synthesis and structure-activity relationships of 7-sulfonylacetamido-3-cephem-4-carboxylic acids.
    DeMarinis RM; Hoover JR; Lam LL; Uri JV; Guarini JR; Phillips L; Actor P; Weisbach JA
    J Med Chem; 1976 Jun; 19(6):754-9. PubMed ID: 781242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro activity of new cephalosporin derivatives containing a benzoxazolone ring.
    Kalcheva V; Mincheva Z; Andreeva P
    Arzneimittelforschung; 1990 Sep; 40(9):1030-4. PubMed ID: 2080938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2000--II. Gram-negative bacteria].
    Suzuki Y; Nishinari C; Endo H; Tamura C; Jinbo K; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Apr; 55(2):154-80. PubMed ID: 12071094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.